NCT03277781

Brief Summary

An abdominal aortic aneurysm (AAA) is a swelling of the main blood vessel (aorta) in the abdomen. If the swelling gets too large the aorta can burst and this is usually fatal. In order to prevent rupture, AAA can be surgically repaired. This is usually carried out when the size of the AAA is more than 5.5cm in diameter as below this size, the risk of rupture is lower than the risk of surgery. AAA are usually asymptomatic before rupture but can easily and safely be diagnosed by ultrasound scanning. There is currently a national screening programme for men, but not women. Women are not screened for AAA on the basis that the disease is less common in females. However, 33.6% of all deaths caused by ruptured AAA in England and Wales are in females (1109 female deaths)1. Death rates due to ruptured AAA in men have nearly halved over the last decade but the reduction in female deaths over the same time period is less than one third. Females with AAA are also 4-times more likely to rupture their aneurysm and have higher rates of complications and death after emergency surgery than men. There are groups of females such as smokers, who are at high risk of AAA. The investigators have identified risk factors that are easily identifiable from general practice databases that may be able to identify women at high risk of AAA. In this research it will be determined whether it is feasible to select women for AAA screening using these risk factors, how many women in these high-risk groups attend if they are invited for AAA screening, and screen women to determine the numbers in the different risk groups who have AAA. This will allow the assessment of whether screening women for AAA could be clinically or cost effective and who would benefit the most. The investigators will also investigate if the siblings of patients with AAAs are at higher risk of disease by inviting them for screening too.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
5,612

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Nov 2016

Typical duration for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

November 1, 2016

Completed
10 months until next milestone

First Submitted

Initial submission to the registry

August 29, 2017

Completed
13 days until next milestone

First Posted

Study publicly available on registry

September 11, 2017

Completed
1.7 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 28, 2019

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

May 28, 2019

Completed
Last Updated

January 30, 2020

Status Verified

September 1, 2019

Enrollment Period

2.6 years

First QC Date

August 29, 2017

Last Update Submit

January 29, 2020

Conditions

Outcome Measures

Primary Outcomes (2)

  • Attendance

    Proportion of women attending for AAA screening

    Day 1

  • Prevalence

    Proportion of women who attend for screening who have an AAA

    Day 1

Study Arms (3)

Current smokers

Other: Screening

Ex-smokers

Other: Screening

Coronary heart disease

Other: Screening

Interventions

Screening for AAA

Coronary heart diseaseCurrent smokersEx-smokers

Eligibility Criteria

Age65 Years - 74 Years
Sexfemale
Healthy VolunteersNo
Age GroupsOlder Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

White women aged 65 to 74 with a history of smoking and/or coronary heart disease

You may qualify if:

  • As per group definitions

You may not qualify if:

  • Any significant disease or disorder which, in the opinion of the Investigator or the patient's general practitioner, may either put the participants at risk because of participation in the study, or may influence the result of the study, or the participant's ability to participate in the study.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University Hospitals of Leicester

Leicester, United Kingdom

Location

MeSH Terms

Conditions

Aortic Aneurysm, Abdominal

Interventions

Mass Screening

Condition Hierarchy (Ancestors)

Aortic AneurysmAneurysmVascular DiseasesCardiovascular DiseasesAortic Diseases

Intervention Hierarchy (Ancestors)

Diagnostic Techniques and ProceduresDiagnosisHealth SurveysSurveys and QuestionnairesData CollectionEpidemiologic MethodsInvestigative TechniquesDiagnostic ServicesPreventive Health ServicesHealth ServicesHealth Care Facilities Workforce and ServicesHealth Care Evaluation MechanismsQuality of Health CareHealth Care Quality, Access, and EvaluationPublic HealthEnvironment and Public HealthPublic Health Practice

Study Design

Study Type
observational
Observational Model
OTHER
Time Perspective
CROSS SECTIONAL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

August 29, 2017

First Posted

September 11, 2017

Study Start

November 1, 2016

Primary Completion

May 28, 2019

Study Completion

May 28, 2019

Last Updated

January 30, 2020

Record last verified: 2019-09

Data Sharing

IPD Sharing
Will not share

Locations